Biomarker Deep Dive: NAD+

NAD⁺ (nicotinamide adenine dinucleotide) is having a moment in longevity—and for good reason: it sits at the intersection of cellular energy, DNA repair, and stress resilience. But NAD⁺ is also a biomarker that’s easy to misread because measurements are sensitive to sample type, handling, and assay method—and “optimal” ranges aren’t universally standardized.

This guide gives you a practical framework: what NAD⁺ is, why it matters, how to interpret results, and what to do next.

TL;DR: What your NAD⁺ result usually means

If your NAD⁺ is low

• Treat it as a signal worth acting on, but don’t over-interpret it as a diagnosis.

• Confirm you’re comparing apples-to-apples: same specimen type, same lab/method, similar conditions.

• Investigate likely drivers: age-related decline mechanisms, inflammation/immune activation, metabolic stress, or low B3 precursor availability.

If your NAD⁺ is borderline / low-normal

• This is often the most actionable zone—especially if your lifestyle includes high stress load, poor sleep, heavy training, frequent alcohol, or metabolic strain.

• Consider tracking trend over time and pairing NAD⁺ with adjacent markers (see “NAD⁺ cluster”).

If your NAD⁺ is “normal” or high

• “Normal” doesn’t automatically mean “optimal,” but it makes a severe depletion story less likely.

• High NAD⁺ can reflect supplement use (NR/NMN), recent lifestyle changes, or lab-specific handling differences—context matters.

Educational content only. NAD⁺ is an emerging biomarker; interpretation should be conservative and trend-focused.

What NAD⁺ is

NAD⁺ is a coenzyme that:

• shuttles electrons in redox reactions (core to energy metabolism)

• serves as a required cofactor/substrate for enzymes involved in DNA repair and cellular regulation, including sirtuins, PARPs, and CD38 

In plain terms: NAD⁺ is a “currency molecule” for energy and repair.

Why NAD⁺ matters

Three big reasons NAD⁺ shows up in longevity and metabolic health conversations:

1. Energy metabolism & mitochondrial function

   NAD⁺/NADH balance is tightly coupled to how cells produce ATP and manage oxidative stress. 

2. DNA damage response and cellular maintenance

   NAD⁺ fuels enzymes that respond to stress and repair processes (e.g., PARP activity), linking it to resilience under chronic stressors. 

3. Age-related decline mechanisms

   Research in animals shows NAD levels can decline with age, and one mechanistic contributor is increased activity of the NAD-consuming enzyme CD38. 

Interpretation: a decision-tree that actually helps

Step 1 — Identify what was measured

NAD biology is broader than a single number. Common readouts include:

• NAD⁺

• NADH

• NAD(H) (combined pool)

• sometimes a NAD⁺/NADH ratio

Also confirm specimen type:

• whole blood vs plasma vs cells (RBC/PBMC)

• dried blood spot (DBS) vs venous blood (if applicable)

These are not interchangeable without lab-specific reference data.

Step 2 — Sanity-check pre-analytics (the hidden factor)

NAD metabolites can be sensitive to handling and extraction. High-quality LC–MS/MS methods emphasize robust separation, internal standards, and stable extraction protocols to avoid mis-quantification. 

Practical takeaway: if you’re re-testing, keep conditions consistent:

• same lab and method (ideally the same panel)

• similar time of day, fasting status, and recent exercise

• similar supplement status (pause/standardize if you’re trying to learn baseline)

Step 3 — Interpret in zones

Zone A: Below reference range

Most likely meaningful. Next move: pair with the NAD⁺ cluster to determine whether this looks like:

• low precursor availability / nutrition pattern

• high consumption (inflammation/stress signaling)

• metabolic strain

Zone B: Borderline / low-normal

Treat this as a “context result.” If you also have:

• fatigue / low recovery (non-specific)

• sleep disruption / high stress load

• metabolic markers trending poorly

  …then trend-tracking + targeted intervention is reasonable.

Zone C: Mid-range normal

Usually reassuring. If symptoms persist, avoid tunnel vision: NAD⁺ is not a diagnosis; consider broader metabolic, thyroid, iron, sleep, and mental health context.

Root causes: why NAD⁺ runs low

Think in three buckets:

1) Increased NAD⁺ consumption

NAD⁺ is used up by enzymes including CD38 and PARPs as part of immune signaling and stress responses. 

Chronic inflammation and immune activation are plausible upstream drivers (not something you can infer from NAD⁺ alone, but it’s a common mechanistic pathway discussed in the literature).

2) Reduced NAD⁺ synthesis / precursor availability

NAD⁺ can be synthesized from vitamin B3-related precursors and salvage pathways. Reviews of NAD metabolism highlight multiple inputs and bottlenecks. 

3) Age-associated shifts in NAD metabolism

Animal research supports an age-related decline in NAD pools and implicates CD38 as one contributor. 

In humans, the picture is more complex, and reference ranges plus clinical implications are still evolving—so treat NAD⁺ as a risk-context biomarker, not a verdict.

What to do next: a practical action plan

Tier 1 — Fix the measurement (fastest ROI)

If you’re making decisions based on NAD⁺:

• re-test under consistent conditions

• keep supplementation consistent (or pause, if safe and appropriate, to measure baseline)

• prefer trend tracking (same method) over comparing across labs

Tier 2 — Lifestyle levers that plausibly support NAD biology

These are “no-regret” moves that affect energy metabolism and stress physiology broadly:

• prioritize sleep regularity

• build aerobic base + strength training without chronic overreaching

• reduce heavy alcohol intake

• manage chronic stress load (volume + recovery)

None of these are “NAD hacks.” They are metabolic hygiene.

Tier 3 — Targeted NAD precursor strategy (慎重, evidence-aware)

Two commonly discussed precursors:

• NR (nicotinamide riboside): extensively studied as an NAD⁺ precursor in humans; reviews discuss bioavailability and safety considerations. 

• NMN (nicotinamide mononucleotide): randomized clinical data show NMN can increase blood NAD concentrations and was well tolerated in a 60-day trial up to 900 mg/day in healthy middle-aged adults. 

Important framing:

• Raising NAD⁺ is not the same as proving long-term clinical benefit.

• If you have active cancer, complex medical conditions, or are pregnant/breastfeeding, do not self-prescribe NAD-related interventions without clinical guidance (risk-benefit is not settled).

Complementary biomarkers to check: the “NAD⁺ cluster”

If NAD⁺ is low/borderline and you want a more informative picture, consider pairing with:

1. NADH and/or NAD(H) (if your lab offers it) 

2. Inflammation context: hs-CRP (non-specific, but useful context)

3. Metabolic context: fasting glucose, HbA1c, triglycerides/HDL

4. Liver context: ALT/AST (metabolic stress proxy)

5. Micronutrient context: vitamin B3 status proxies are not standardized clinically, but diet/supplement review is often more practical

6. If your panel supports it: NAD precursors/metabolites (NAM, NR/NMN, methylated metabolites) — best interpreted within the same method suite 

FAQ

Is NAD⁺ a “longevity biomarker”?

It’s better described as a mechanistic metabolic biomarker with strong relevance to pathways of aging (energy, DNA repair, immune signaling). The clinical “longevity score” interpretation is still emerging. 

Should I focus on NAD⁺ alone?

No. NAD⁺ is context-dependent and sensitive to measurement conditions. It’s most useful when:

• tracked over time with consistent method

• paired with a small cluster of metabolic and inflammation context markers

Can supplements raise NAD⁺?

Human data show that NMN can increase blood NAD concentrations in controlled settings.  NR is also widely studied as an NAD⁺ precursor with a growing evidence base. 

Whether that translates into durable, meaningful health outcomes depends on population, dose, duration, and endpoints.

What’s the “best” NAD intervention?

Usually: sleep + training + metabolic health first. Precursor supplementation is a tier-3 lever—potentially helpful, but not a replacement for basics.

References

1) Covarrubias AJ, Perrone R, Grozio A, Verdin E. “NAD+ metabolism and its roles in cellular processes during ageing.” (2020, review; PMC) (Link)

2) Camacho-Pereira J, Tarragó MG, Chini CCS, et al. “CD38 dictates age-related NAD decline and mitochondrial dysfunction through a SIRT3-dependent mechanism.” (2016; PMC) (Link)

3) Schultz MB, Sinclair DA. “Why NAD+ Declines during Aging: It’s Destroyed.” (2016, Cell Metabolism) (Link)

4) Ishima T, et al. “A Simple, Fast, Sensitive LC-MS/MS Method to Quantify NAD(H) in Biological Samples.” (2024; PMC) (Link)

5) Nacham O, et al. “A mixed-mode LC-MS-based method for comprehensive analysis of NAD+ precursors and metabolites.” (2025, Scientific Reports) (Link)

6) Chini CCS, et al. “Evolving concepts in NAD+ metabolism.” (2021, perspective; Europe PMC entry) (Link)

7) Mehmel M, Jovanović N, Spitz U. “Nicotinamide Riboside—The Current State of Research and Therapeutic Uses.” (2020; PMC) (Link)

8) Yi L, et al. “The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation… randomized clinical trial.” (2023; PubMed) (Link)

9) Balashova NV, et al. “Efficient Assay and Marker Significance of NAD+ in Human Blood.” (2022, Frontiers in Medicine) (Link)